Results 71 to 80 of about 19,681 (252)

Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations

Current Medical Research and Opinion, 2020
Objective: Varenicline, a selective partial agonist of the α4β2 nicotinic acetylcholine receptor, is a smoking cessation pharmacotherapy that more than doubles the chance of quitting smoking at 6 months compared with placebo. This article reviews salient
S. Tonstad, C. Arons, H. Rollema, I. Berlin, P. Hajek, K. Fagerström, C. Els, T. McRae, C. Russ   +8 more
semanticscholar   +1 more source

Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis

Pharmacoepidemiology and Drug Safety, 2021
Varenicline is an effective treatment for smoking cessation. While clinical trials did not confirm a causal role, case reports suggested a possible link of varenicline with neuropsychiatric adverse drug events (NPAEs).
Yuanyuan Wang, J. Boven, J. Bos, C. Schuiling-Veninga, H. Boezen, B. Wilffert, E. Hak   +6 more
semanticscholar   +1 more source

Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink

Health Technology Assessment, 2020
Background: Smoking is the leading avoidable cause of illness and premature mortality. The first-line treatments for smoking cessation are nicotine replacement therapy and varenicline.
Neil M Davies, Amy E Taylor, Gemma MJ Taylor, Taha Itani, Tim Jones, Richard M Martin, Marcus R Munafò, Frank Windmeijer, Kyla H Thomas   +8 more
doaj   +1 more source

Effectiveness of varenicline and counseling for smoking cessation in an observational cohort study in China [PDF]

, 2016
published_or_final_versio
Chan, SSC, Cheng, KK, He, Y, Jiang, B, Lam, TH, Liu, QH, Wu, L, Zhang, L, Zhou, CX, Zuo, F   +9 more
core   +1 more source

Vaping cessation strategies and triggers for relapse amongst people from New Zealand who have vaped

Drug and Alcohol Review, EarlyView.
Abstract Introduction In New Zealand (NZ) vapes (e‐cigarettes) are a government‐endorsed strategy to help people stop smoking, as well as being used recreationally by people who have never smoked. Nicotine vapes are addictive and many users want to quit.
Mehdi Rahimi, Bodo Lang, Lion Shahab, Jamie Brown, Amanda Palmer, Joya Kemper, Chris Bullen, George Laking, Vili Nosa, Varsha Parag, Natalie Walker   +10 more
wiley   +1 more source

The association between self-reported varenicline adherence and varenicline blood levels in a sample of cancer patients receiving treatment for tobacco dependence

Addictive Behaviors Reports, 2018
Introduction: The degree to which smokers quit successfully with varenicline is strongly associated with their adherence to the medication regimen. Thus, measuring varenicline adherence to identify smokers needing additional intervention is a priority ...
Grace Crawford, Nancy Jao, Annie R. Peng, Frank Leone, Ravi Kalhan, Rachel F. Tyndale, Jessica Weisbrot, Brian Hitsman, Robert Schnoll   +8 more
doaj  

Visual hallucinations associated with varenicline: a case report

Journal of Medical Case Reports, 2009
Introduction Varenicline is widely used for smoking cessation. It has shown efficacy over placebo and bupropion in manufacturer-sponsored trials. Those with mental illness were excluded from these trials.
Raidoo B Mahendri, Kutscher Eric C
doaj   +1 more source

The Food and Drug Administration and varenicline:should Risk Communication Be Improved? [PDF]

, 2016
[no ...
Davies, Neil M, Thomas, Kyla H
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Identifying determinants of varenicline adherence using the Theoretical Domains framework: a rapid review

BMC Public Health
Background Adhering to varenicline has been shown to significantly improve the chances of successfully quitting smoking, with studies indicating a twofold increase in 6-month quit rates.
Nadia Minian, Melissa Wong, Sowsan Hafuth, Terri Rodak, Alma Rahimi, Dea Gjomema, Jonathan Rose, Laurie Zawertailo, Matt Ratto, Peter Selby   +9 more
doaj   +1 more source